Similarly, while stimulation of glioma cells with soluble DLK1 boosted the increase in the expression of the stem cell marker genes NANOG, OCT4, and SOX2 in hypoxic cells, addition of PT2385 blocked this specific DLK1 effect in all cell lines tested (Figure 6B). This evidence concerns the gene DLK1 and central nervous system cancer.